Suppr超能文献

关于癌症患者使用草药和补充剂的美国肿瘤学家知识、态度及实践模式的全国性调查。

National survey of US oncologists' knowledge, attitudes, and practice patterns regarding herb and supplement use by patients with cancer.

作者信息

Lee Richard T, Barbo Andrea, Lopez Gabriel, Melhem-Bertrandt Amal, Lin Heather, Olopade Olufunmilayo I, Curlin Farr A

机构信息

Richard T. Lee, Andrea Barbo, Gabriel Lopez, Amal Melhem-Bertrandt, and Heather Lin, University of Texas MD Anderson Cancer Center, Houston, TX; Olufunmilayo I. Olopade, University of Chicago, Chicago, IL; and Farr A. Curlin, Duke University, Durham, NC.

出版信息

J Clin Oncol. 2014 Dec 20;32(36):4095-101. doi: 10.1200/JCO.2014.55.8676. Epub 2014 Nov 17.

Abstract

PURPOSE

Patients with cancer commonly use complementary and alternative medicine, including herbs and supplements (HS), during cancer treatment. This national survey explored oncologists' knowledge, attitudes, and practice patterns regarding HS use by their patients.

METHODS

A survey was sent by mail and e-mail to a random sample of 1,000 members of the American Society for Clinical Oncology. The questions covered several topics: communication patterns, attitudes about HS, education about HS, response to HS use among hypothetical patients with cancer, knowledge of HS adverse effects, and demographic information.

RESULTS

Among eligible oncologists, 392 (42%) responded to the questionnaire. Most were white (75%) men (71%), with a mean age of 48 years (standard deviation, 9.8 years). On average, oncologists discussed use of HS with 41% of their patients; only 26% of discussions were initiated by the oncologist. Two of three oncologists indicated they did not have enough knowledge to answer questions from patients regarding HS, and 59% had not received any education about the topic. Physician factors associated with having initiated discussions with patients about the use of HS included female sex, higher self-reported knowledge, prior education about HS, increased knowledge about HS adverse effects and interactions, and estimating that > 40% of one's patients with cancer use HS.

CONCLUSION

Fewer than one half of oncologists are initiating discussions with patients about HS use, and many indicate that lack of knowledge and education is a barrier to such discussions. Improving physician education about HS may facilitate more physician-patient communication about this important topic.

摘要

目的

癌症患者在癌症治疗期间通常会使用补充和替代医学,包括草药和补充剂(HS)。这项全国性调查探讨了肿瘤学家对其患者使用HS的知识、态度和实践模式。

方法

通过邮件和电子邮件向美国临床肿瘤学会的1000名成员随机抽样发送调查问卷。问题涵盖几个主题:沟通模式、对HS的态度、关于HS的教育、对假设的癌症患者使用HS的反应、对HS不良反应的了解以及人口统计学信息。

结果

在符合条件的肿瘤学家中,392人(42%)回复了问卷。大多数是白人(75%)男性(71%),平均年龄48岁(标准差9.8岁)。肿瘤学家平均与41%的患者讨论过HS的使用;只有26%的讨论是由肿瘤学家发起的。三分之二的肿瘤学家表示他们没有足够的知识来回答患者关于HS的问题,59%的人没有接受过关于该主题的任何教育。与发起与患者讨论HS使用相关的医生因素包括女性、自我报告的知识水平较高、之前接受过关于HS的教育、对HS不良反应和相互作用的了解增加,以及估计自己超过40%的癌症患者使用HS。

结论

不到一半的肿瘤学家会主动与患者讨论HS的使用,许多人表示缺乏知识和教育是此类讨论的障碍。改善医生对HS的教育可能有助于就这个重要话题进行更多的医患沟通。

相似文献

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验